|
|
Join Biotech and Pharma industry experts as they converse on deal making trends. Learn how you can position your technology and/or company for success in the current environment.   Our seasoned panel will discuss the evolution of deal models in the life science industry from the 1980s to present day. Our panelist will touch upon issues relating to the size of the deals, valuations, early stage /late stage deals, and recent acquisition activity (Takeda/Millennium; AstraZeneca/MedImmune; Imclone/Lilly). A must attend for anyone interested in Biotech Pharma deal making.
|
|
Video Length: 4800
Date Found: June 27, 2011
Date Produced: June 26, 2011
|
|
 MIT TechTV |
July 13, 2011
|
 MIT TechTV |
July 07, 2011
|
 MIT TechTV |
June 27, 2011
The emerging cleantech venture`s pilot has been supported by government grants now it is time to scale. Cleantech requires significant funding, often larger than traditional vc`s are structured to support. How does a cleantech venture scale to grow? Hear from national project developer ...
|
 MIT TechTV |
June 27, 2011
Three leading New York venture capital firms will provide their strategies for 2011. Understanding venture capital firms’ strategies is critical in order to obtain venture capital. Prior to the panel discussion, PwC will present a summary of the 3rd quarter 2010 MoneyTree Report. The MoneyTree ...
|
 MIT TechTV |
June 27, 2011
With the recent passage of healthcare reform legislation, corporate consolidations, and a `get tough` policy at the FDA, it is difficult to tell what the commercial healthcare landscape will look like during the next five years. A distinguished panel of experts representing biopharmaceuticals, ...
|
|
|
|
|
|
Featured
Content
Featuring websites that enhance the internet user’s experience.
|